Inventor · disambiguated record
John J. M. Wiener
Also filed as: WIENER JOHN J M
27 granted patents·9 pending applications·52 citations·filing 2006–2025
94Inventor score
Files withJANSSEN PHARMACEUTICA NV15H LUNDBECK AS9ABIDE THERAPEUTICS INC3LUNDBECK LA JOLLA RESEARCH CENTER INC3ALLISON BRETT D2
Top patents by PatentIndex Score
36 records- 0196US10927105B1Pyrazole MAGL inhibitorsLUNDBECK LA JOLLA RESEARCH CENTER INC·Filed 2020·Granted Feb 23, 2021·5 cites·12 claims
- 0294US10266497B2Pyrazole MAGL inhibitorsABIDE THERAPEUTICS INC·Filed 2018·Granted Apr 23, 2019·9 cites·20 claims
- 0393US11434222B2MAGL inhibitorsH LUNDBECK AS·Filed 2021·Granted Sep 6, 2022·2 cites·12 claims
- 0491US12065446B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Aug 20, 2024·1 cites·4 claims
- 0591US10717745B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 21, 2020·5 cites·26 claims
- 0690US12378219B2Crystalline forms of a MAGL inhibitorH LUNDBECK AS·Filed 2023·Granted Aug 5, 2025·1 cites·9 claims
- 0790US10934310B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 2, 2021·4 cites·7 claims
- 0886US11129827B2Dual MAGL and FAAH inhibitorsABIDE THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·2 cites·16 claims
- 0986US2024383914A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1085US11149037B2Pyrazole MAGL inhibitorsH LUNDBECK AS·Filed 2018·Granted Oct 19, 2021·3 cites·24 claims
- 1184US11655217B2Pyrazole MAGL inhibitorsH LUNDBECK AS·Filed 2018·Granted May 23, 2023·2 cites·20 claims
- 1284US11319329B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·7 claims
- 1381US10350205B2Dual MAGL and FAAH inhibitorsABIDE THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·2 cites·17 claims
- 1481US8952177B21,2,6-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 10, 2015·4 cites·9 claims
- 1579US9089569B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 28, 2015·3 cites·13 claims
- 1679US8357684B2Thyazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 22, 2013·5 cites·21 claims
- 1778US2025262205A1Dual magl and faah inhibitorsLUNDBECK LA JOLLA RESEARCH CENTER INC·Filed 2025·Application pending·0 cites
- 1875US12318383B2Dual MAGL and FAAH inhibitorsLUNDBECK LA JOLLA RESEARCH CENTER INC·Filed 2021·Granted Jun 3, 2025·0 cites·15 claims
- 1975US7939527B2Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2009·Granted May 10, 2011·2 cites·37 claims
- 2073US12258340B2Pyrazole MAGL inhibitorsH LUNDBECK AS·Filed 2023·Granted Mar 25, 2025·0 cites·20 claims
- 2172US7842810B2Bicyclic pyrazole compounds as antibacterial agentsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Nov 30, 2010·1 cites·2 claims
- 2268US2025326737A1Crystalline forms of a magl inhibitorH LUNDBECK AS·Filed 2025·Application pending·0 cites
- 2365US10800792B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 13, 2020·0 cites·4 claims
- 2465US2024018120A1Magl inhibitorsH LUNDBECK AS·Filed 2021·Application pending·0 cites
- 2564US10822348B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 3, 2020·0 cites·10 claims
- 2659US12152029B2Crystalline forms of a MAGL inhibitorH LUNDBECK AS·Filed 2022·Granted Nov 26, 2024·0 cites·25 claims
- 2759US9695149B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 4, 2017·0 cites·20 claims
- 2858US10689396B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 23, 2020·0 cites·23 claims
- 2958US2023013755A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 3050US8242275B2Bicyclic pyrazole compounds as antibacterial agentsALLISON BRETT D·Filed 2010·Granted Aug 14, 2012·0 cites·28 claims
- 3147US8232391B2Bicyclic pyrazole compounds as antibacterial agentsALLISON BRETT D·Filed 2010·Granted Jul 31, 2012·0 cites·26 claims
- 3247US2008200454A1Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin sAMERIKS MICHAEL K·Filed 2008·Application pending·0 cites
- 3346US2009099157A1Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin sAMERIKS MICHAEL K·Filed 2008·Application pending·0 cites
- 3444US2022031676A1Methods of treating disease with magl inhibitorsH LUNDBECK AS·Filed 2019·Application pending·0 cites
- 3540US2020079790A1Methods of selective aryl- and heteroaryl-nitrogen bond formationJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2018·Application pending·0 cites
- 3628US8399465B2Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolaseBACANI GENESIS·Filed 2010·Granted Mar 19, 2013·0 cites·54 claims
Join the waitlist — get patent alerts
Get an alert when John J. M. Wiener files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →